Filing Flows

Filing Flows › Eton Pharmaceuticals (ETON) › Next earnings date

Eton Pharmaceuticals (ETON) earnings: beat the estimate

Eton Pharmaceuticals (ETON) reported on Nov 5, 2026 and beat the EPS estimate: $0.50 against $0.37 (+35.1%). Revenue was $57.9M for Q3 2026, +158% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result+35.1% vs estimate
Beat rate40%

The last report

Eton Pharmaceuticals reported revenue of $57.9M for the third quarter 2026 (+158% Y/Y), net earnings $35.2M. How it makes money → · Every quarter →

Eton Pharmaceuticals: EPS against the estimate, last 5 reportsEton Pharmaceuticals: EPS against the estimate, last 5 reportsEstimateReported$0.16$0.04Nov 25$0.20$0.19Mar 26$0.14$0.14May 26$0.19$0.43Aug 26$0.37$0.50Nov 26
Latest (Nov 26): Estimate $0.37, Reported $0.50.

Eton Pharmaceuticals' latest quarter

Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did Eton Pharmaceuticals beat earnings?

Eton Pharmaceuticals (ETON) reported on Nov 5, 2026 and beat the EPS estimate: $0.50 against $0.37 (+35.1%).

When does ETON report earnings?

The next date is not set yet.

Does Eton Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.